Logo image of OM

OUTSET MEDICAL INC (OM) Stock Fundamental Analysis

USA - NASDAQ:OM - US6901452069 - Common Stock

14.21 USD
-0.17 (-1.18%)
Last: 10/28/2025, 4:16:26 PM
14.21 USD
0 (0%)
After Hours: 10/28/2025, 4:16:26 PM
Fundamental Rating

2

Taking everything into account, OM scores 2 out of 10 in our fundamental rating. OM was compared to 189 industry peers in the Health Care Equipment & Supplies industry. OM may be in some trouble as it scores bad on both profitability and health. OM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OM has reported negative net income.
OM had a negative operating cash flow in the past year.
OM had negative earnings in each of the past 5 years.
OM had a negative operating cash flow in each of the past 5 years.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

OM has a Return On Assets of -33.90%. This is comparable to the rest of the industry: OM outperforms 40.74% of its industry peers.
OM's Return On Equity of -63.25% is in line compared to the rest of the industry. OM outperforms 46.56% of its industry peers.
Industry RankSector Rank
ROA -33.9%
ROE -63.25%
ROIC N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

The Gross Margin of OM (36.46%) is worse than 69.31% of its industry peers.
In the last couple of years the Gross Margin of OM has grown nicely.
The Profit Margin and Operating Margin are not available for OM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OM has more shares outstanding
OM has more shares outstanding than it did 5 years ago.
OM has a worse debt/assets ratio than last year.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OM has an Altman-Z score of -3.85. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OM (-3.85) is worse than 66.67% of its industry peers.
OM has a Debt/Equity ratio of 0.61. This is a neutral value indicating OM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, OM is not doing good in the industry: 66.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z -3.85
ROIC/WACCN/A
WACC6.8%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

OM has a Current Ratio of 7.47. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
OM has a Current ratio of 7.47. This is amongst the best in the industry. OM outperforms 87.83% of its industry peers.
A Quick Ratio of 6.05 indicates that OM has no problem at all paying its short term obligations.
The Quick ratio of OM (6.05) is better than 86.24% of its industry peers.
Industry RankSector Rank
Current Ratio 7.47
Quick Ratio 6.05
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.90% over the past year.
OM shows a small growth in Revenue. In the last year, the Revenue has grown by 2.47%.
OM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.74% yearly.
EPS 1Y (TTM)55.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.09%
Revenue 1Y (TTM)2.47%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%14.72%

3.2 Future

The Earnings Per Share is expected to grow by 14.80% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.26% on average over the next years. This is quite good.
EPS Next Y83.58%
EPS Next 2Y37.86%
EPS Next 3Y24.17%
EPS Next 5Y14.8%
Revenue Next Year10.17%
Revenue Next 2Y10.34%
Revenue Next 3Y10.66%
Revenue Next 5Y13.26%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OM. In the last year negative earnings were reported.
Also next year OM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

OM's earnings are expected to grow with 24.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.86%
EPS Next 3Y24.17%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTSET MEDICAL INC

NASDAQ:OM (10/28/2025, 4:16:26 PM)

After market: 14.21 0 (0%)

14.21

-0.17 (-1.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners98.73%
Inst Owner Change2.02%
Ins Owners1.94%
Ins Owner Change23.71%
Market Cap252.51M
Revenue(TTM)119.30M
Net Income(TTM)-97902000
Analysts85
Price Target26.27 (84.87%)
Short Float %11.83%
Short Ratio8.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-107.94%
Min EPS beat(2)-232.87%
Max EPS beat(2)16.99%
EPS beat(4)3
Avg EPS beat(4)-48.19%
Min EPS beat(4)-232.87%
Max EPS beat(4)16.99%
EPS beat(8)4
Avg EPS beat(8)-23.9%
EPS beat(12)5
Avg EPS beat(12)-18.54%
EPS beat(16)6
Avg EPS beat(16)-15.76%
Revenue beat(2)2
Avg Revenue beat(2)3.79%
Min Revenue beat(2)3.73%
Max Revenue beat(2)3.86%
Revenue beat(4)4
Avg Revenue beat(4)2.88%
Min Revenue beat(4)0.47%
Max Revenue beat(4)3.86%
Revenue beat(8)4
Avg Revenue beat(8)-2.34%
Revenue beat(12)8
Avg Revenue beat(12)-0.7%
Revenue beat(16)10
Avg Revenue beat(16)-1.02%
PT rev (1m)0%
PT rev (3m)-2.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25.99%
EPS NY rev (1m)0%
EPS NY rev (3m)16.73%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.12
P/FCF N/A
P/OCF N/A
P/B 1.63
P/tB 1.63
EV/EBITDA N/A
EPS(TTM)-15.48
EYN/A
EPS(NY)-2.68
Fwd EYN/A
FCF(TTM)-3.85
FCFYN/A
OCF(TTM)-3.8
OCFYN/A
SpS6.71
BVpS8.71
TBVpS8.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.9%
ROE -63.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.46%
FCFM N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.26%
Cap/Sales 0.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.47
Quick Ratio 6.05
Altman-Z -3.85
F-Score6
WACC6.8%
ROIC/WACCN/A
Cap/Depr(3y)78.75%
Cap/Depr(5y)116.96%
Cap/Sales(3y)3.55%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.09%
EPS Next Y83.58%
EPS Next 2Y37.86%
EPS Next 3Y24.17%
EPS Next 5Y14.8%
Revenue 1Y (TTM)2.47%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%14.72%
Revenue Next Year10.17%
Revenue Next 2Y10.34%
Revenue Next 3Y10.66%
Revenue Next 5Y13.26%
EBIT growth 1Y47.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.9%
EBIT Next 3Y16.81%
EBIT Next 5Y15.58%
FCF growth 1Y53.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.35%
OCF growth 3YN/A
OCF growth 5YN/A

OUTSET MEDICAL INC / OM FAQ

What is the fundamental rating for OM stock?

ChartMill assigns a fundamental rating of 2 / 10 to OM.


What is the valuation status of OUTSET MEDICAL INC (OM) stock?

ChartMill assigns a valuation rating of 1 / 10 to OUTSET MEDICAL INC (OM). This can be considered as Overvalued.


How profitable is OUTSET MEDICAL INC (OM) stock?

OUTSET MEDICAL INC (OM) has a profitability rating of 1 / 10.


What is the financial health of OUTSET MEDICAL INC (OM) stock?

The financial health rating of OUTSET MEDICAL INC (OM) is 3 / 10.